Heejin Lim

880 total citations
12 papers, 681 citations indexed

About

Heejin Lim is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heejin Lim has authored 12 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heejin Lim's work include Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Heejin Lim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Heejin Lim collaborates with scholars based in South Korea and United States. Heejin Lim's co-authors include Woo‐Ri Shin, Hyun Tae Lee, Yong-Seok Heo, Seong Eon Ryu, Ju‐Yeun Lee, Sang Hyung Lee, Ji Young Son, Yeon Ji Lee, Sung‐Gyoo Park and Yong‐Seok Heo and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Heejin Lim

11 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heejin Lim South Korea	8	343	256	193	160	57	12	681
Berend Neuteboom United States	13	476 1.4×	286 1.1×	251 1.3×	202 1.3×	59 1.0×	19	877
Weining Ma United States	13	301 0.9×	145 0.6×	524 2.7×	152 0.9×	73 1.3×	25	887
Sophia Frentzas Australia	14	388 1.1×	121 0.5×	276 1.4×	92 0.6×	112 2.0×	65	737
Kazutoshi Murata Japan	15	259 0.8×	175 0.7×	127 0.7×	125 0.8×	63 1.1×	53	751
Jane Ruppel United States	13	224 0.7×	221 0.9×	162 0.8×	144 0.9×	49 0.9×	19	633
Brigitte Gückel Germany	17	275 0.8×	374 1.5×	367 1.9×	278 1.7×	220 3.9×	40	1.0k
David Kan United States	13	322 0.9×	110 0.4×	368 1.9×	310 1.9×	46 0.8×	22	805
Gary Li United States	13	197 0.6×	136 0.5×	355 1.8×	128 0.8×	74 1.3×	32	702
Marc W. Retter United States	18	231 0.7×	667 2.6×	411 2.1×	475 3.0×	72 1.3×	37	1.4k
R. Angelo de Claro United States	15	424 1.2×	201 0.8×	202 1.0×	62 0.4×	59 1.0×	40	815

Countries citing papers authored by Heejin Lim

Since Specialization

Citations

This map shows the geographic impact of Heejin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heejin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heejin Lim more than expected).

Fields of papers citing papers by Heejin Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heejin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heejin Lim. The network helps show where Heejin Lim may publish in the future.

Co-authorship network of co-authors of Heejin Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Heejin Lim. A scholar is included among the top collaborators of Heejin Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heejin Lim. Heejin Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Choi, Jae‐Sun, Kiyong Na, Taewoo Kim, et al.. (2024). KEAP1-NRF2 Pathway as a Novel Therapeutic Target for EGFR-Mutant Non-small Cell Lung Cancer. Tuberculosis & respiratory diseases. 88(1). 138–149. 3 indexed citations

2.

Lim, Heejin, et al.. (2021). TGF-β Increases MFGE8 Production in Myeloid-Derived Suppressor Cells to Promote B16F10 Melanoma Metastasis. Biomedicines. 9(8). 896–896. 6 indexed citations

3.

Lee, Sang Hyung, et al.. (2020). Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy. Biochemical and Biophysical Research Communications. 527(1). 226–231. 20 indexed citations

4.

Lee, Ju Yeon, Hyun Tae Lee, Sang Hyung Lee, Heejin Lim, & Yong‐Seok Heo. (2019). Crystal Structure of the Fab Fragment of an Anti‐CTLA‐4 Antibody, Ipilimumab, Used for Cancer Immunotherapy. Bulletin of the Korean Chemical Society. 40(6). 582–585.

5.

Lim, Heejin, et al.. (2018). Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis. International Journal of Molecular Sciences. 19(3). 768–768. 76 indexed citations

6.

Lim, Heejin, et al.. (2018). Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses. International Journal of Molecular Sciences. 19(5). 1468–1468. 38 indexed citations

7.

Shin, Woo‐Ri, Hyun Tae Lee, Heejin Lim, et al.. (2018). BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus. Nature Communications. 9(1). 29 indexed citations

8.

Lee, Hyun Tae, Ju‐Yeun Lee, Heejin Lim, et al.. (2017). Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab. Scientific Reports. 7(1). 5532–5532. 174 indexed citations

9.

Lee, Ju‐Yeun, Hyun Tae Lee, Woo‐Ri Shin, et al.. (2016). Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy. Nature Communications. 7(1). 13354–13354. 219 indexed citations

10.

Schindewolf, Craig, Takemi Tanaka, Rajendra Gharbaran, et al.. (2014). Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. Journal of Ovarian Research. 7(1). 109–109. 33 indexed citations

11.

Schindewolf, Craig, Takemi Tanaka, Rajendra Gharbaran, et al.. (2014). Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. Journal of Ovarian Research. 7(1). 109–109. 3 indexed citations

12.

Lim, Heejin, Shihong Li, Shifang Zhang, et al.. (2012). Early Detection Biomarkers for Ovarian Cancer. Journal of Oncology. 2012. 1–15. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact